Cite
HARVARD Citation
Egeli, D. et al. (2022). SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment. Leukemia & lymphoma. 63 (4), pp. 955-962. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Egeli, D. et al. (2022). SOCS-2 gene expression at diagnosis does not predict for outcome of chronic myeloid leukemia patients on imatinib treatment. Leukemia & lymphoma. 63 (4), pp. 955-962. [Online].